REVANCE THERAPEUTICS LTD

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 2002-01-01

Employees: 597

Market Cap: $685.5M

Website: http://www.revance.com

Clinical Trials

Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines

Phase 2

Recruiting

Conditions: Glabellar Frown Lines

Interventions: Drug: DAXXIFY

First Posted Date: 2024-05-13

Last Posted Date: 2024-05-22

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 30

Registration Number: NCT06411002

Locations: 🇺🇸
Revance, Nashville, Tennessee, United States

Teosyal RHA® Histology and Intradermal Implantation Evaluation Study

Conditions: Histology

Interventions: Device: RHA® 1, RHA® 2, RHA® 3, and RHA® 4

First Posted Date: 2021-04-15

Last Posted Date: 2021-12-01

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 8

Registration Number: NCT04846530

Locations: 🇨🇦
Woodbridge, Ontario Site, Woodbridge, Ontario, Canada

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Phase 2

Completed

Conditions: Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)

Interventions: Drug: DaxibotulinumtoxinA for injection

First Posted Date: 2020-02-06

Last Posted Date: 2023-06-27

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 48

Registration Number: NCT04259086

Locations: 🇺🇸
Site 7, Santa Monica, California, United States
🇨🇦
Site 4, Vancouver, British Columbia, Canada
🇺🇸
Site 1, Manhattan Beach, California, United States

and more 5 locations

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

Phase 2

Completed

Conditions: Lateral Canthal Lines

Interventions: Biological: DaxibotulinumtoxinA for injection

First Posted Date: 2019-04-10

Last Posted Date: 2023-06-27

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 63

Registration Number: NCT03911102

Locations: 🇺🇸
Sarasota, FL Site, Sarasota, Florida, United States
🇺🇸
Itasca, IL Site, Itasca, Illinois, United States
🇺🇸
Arlington, VA Site, Arlington, Virginia, United States

and more 1 locations

DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis

Phase 2

Completed

Conditions: Plantar Fasciitis

Interventions: Biological: DAXI 80 U
Other: Placebo
Biological: DAXI 120 U

First Posted Date: 2019-01-31

Last Posted Date: 2023-09-21

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 155

Registration Number: NCT03825315

Locations: 🇺🇸
Kansas Institute of Research, Overland Park, Kansas, United States
🇺🇸
Advanced Foot & Ankle Center, Las Vegas, Nevada, United States
🇺🇸
Rocky Mountain Foot and Ankle, LLC, Salt Lake City, Utah, United States

and more 16 locations

Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity

Phase 2

Completed

Conditions: Upper Limb Spasticity

Interventions: Biological: DAXI for injection 500 U
Biological: DAXI for injection 250 U
Biological: DAXI for injection 375 U
Other: Placebo

First Posted Date: 2019-01-29

Last Posted Date: 2023-09-21

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 83

Registration Number: NCT03821402

Locations: 🇺🇸
Kansas Institute of Research, Overland Park, Kansas, United States
🇺🇸
The Parkinsons and Movement Disorder Institute, Fountain Valley, California, United States
🇺🇸
SC3 Research, Pasadena, California, United States

and more 23 locations

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

Phase 2

Completed

Conditions: Frown Lines

Interventions: Biological: DaxibotulinumtoxinA for injection

First Posted Date: 2018-12-26

Last Posted Date: 2023-02-16

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 61

Registration Number: NCT03786770

Locations: 🇺🇸
Boca Raton site, Boca Raton, Florida, United States
🇨🇦
Toronto, Ontario site, Toronto, Ontario, Canada
🇺🇸
Coral Gables site, Coral Gables, Florida, United States

and more 1 locations

Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)

Phase 3

Completed

Conditions: Cervical Dystonia

Interventions: Biological: daxibotulinumtoxinA for injection

First Posted Date: 2018-08-06

Last Posted Date: 2022-01-28

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 357

Registration Number: NCT03617367

Locations: 🇺🇸
The University of Vermont Medical Center, Burlington, Vermont, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
QUEST Research Institute, Farmington, Michigan, United States

and more 62 locations

Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)

Phase 3

Completed

Conditions: Cervical Dystonia

Interventions: Biological: Placebo
Biological: DaxibotulinumtoxinA for injection

First Posted Date: 2018-08-01

Last Posted Date: 2022-12-05

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 301

Registration Number: NCT03608397

Locations: 🇦🇹
Medical University Innsbruck, Innsbruck, Austria
🇵🇱
Centrum Medyczne Pratia Warszawa, Warsaw, Poland
🇺🇸
New England Institute for Clinical Research, Stamford, Connecticut, United States

and more 72 locations

Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Phase 2

Completed

Conditions: Plantar Fasciitis

Interventions: Biological: Placebo
Biological: Botulinum Toxins, Type A

First Posted Date: 2017-05-02

Last Posted Date: 2023-09-18

Lead Sponsor: Revance Therapeutics, Inc.

Target Recruit Count: 59

Registration Number: NCT03137407

Locations: 🇺🇸
Village Podiatry Centers, Duluth, Georgia, United States
🇺🇸
Weil Foot and Ankle Institute, Des Plaines, Illinois, United States
🇺🇸
Kansas City Bone & Joint Clinic, Overland Park, Kansas, United States

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy